ACCESS model: payment tied to biomarker achievement
Metric MV-02 · Series MV: Medicare Innovation
ACCESS model: payment tied to biomarker achievement was Up to 50% in 2026, according to CMS Innovation Center.
This figure is reported as Metric MV-02 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures access model: payment tied to biomarker achievement among access model participants. The unit of measurement is percent of Outcome-Aligned Payment. The geographic scope is United States.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| Up to 50% | 2026 | ACCESS model participants | United States |
Source
CMS Innovation Center.
Methodological Notes
This figure is drawn from CMS Innovation Center. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
- MV-01ACCESS model: clinical tracks addressing metabolic health
- MV-03ACCESS model: minimum beneficiary target for full payment (Year 1)
- MV-04ACCESS model: planned duration
- MV-05Medicare Diabetes Prevention Program: active participants vs. eligible population
- MV-06ACCESS model: required biomarker measure categories
Cite This Metric
Last reviewed: October 2026